Sign in

CIK 0001649989

  • Non-accelerated filer
  • Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
383982704
Phone
+1 609-619-3990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-10-31 Thomas Joe Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2017-10-31 GMS Tenshi Holdings Pte. Ltd Chief Executive Officer Purchase · Series A Convertible Preferred Stock +217,372 $100.00 $21.7M 250,000
2017-10-31 GMS Tenshi Holdings Pte. Ltd Chief Executive Officer Purchase · Warrants +16,750,000 16,750,000
2017-10-26 HILZINGER KURT J Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2017-10-26 Brady Todd C Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2017-10-26 Canute Scott A Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2017-10-26 Dyrness Albert D. Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2017-01-23 HILZINGER KURT J Director Option exercise +12,036 $0.01 $120 30,554
2017-01-23 HILZINGER KURT J Director Option exercise · Warrant (Right to Buy) −12,036 0
2016-12-22 Dyrness Albert D. Director Purchase · Warrant (Right to Buy) +11,500 11,500
2016-12-22 Canute Scott A Director Purchase · Warrant (Right to Buy) +80,500 80,500
2016-12-21 KENYON LAWRENCE A CFO and Secretary Grant or award +50,000 93,478
2016-12-21 MCANDREW STEPHEN J SVP Bus. Strat. & Dev. Grant or award +30,000 66,604
2016-12-21 Yamashita Elizabeth A. VP, Regulatory Affairs Grant or award +45,000 88,478
2016-12-21 Gangloff Scott A. SVP, Development & Mfrg Grant or award +40,000 118,573
2016-12-21 Bahrt Kenneth Chief Medical Officer Grant or award +50,000 80,985
2016-12-21 Bao Kogan VP, Analytical Sciences Grant or award +50,000 71,739
2016-11-30 HILZINGER KURT J Director Other acquisition +6,885 18,518
2016-11-28 Smith Hoke Robin Director Other acquisition +1,939 1,939
2016-11-28 Smith Hoke Robin Director Other acquisition · Warrant (Right to Buy) +1,260 1,260

Page 18 of 20 · 386 trades